跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SP-10
首页
药物
SP-10
SP-10
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Process for the preparation of protease inhibitor using novel alkalothermophilic Bacillus sp
US 2005142125 A1
申请人: DASH CHANDRAVANU
优先权: 2000
US
4 件公开
CURABLE DENTAL COMPOSITION
EP 3682862 A4
申请人: TOKUYAMA DENTAL CORP
优先权: 2017
CN
EP
US
3 件公开
Microorganism, its product and utilization thereof
US 7115721 B2
申请人: NAGASE & CO LTD
优先权: 2002
EP
US
3 件公开
Skin clarifying complex, use of said complex, cosmestic or pharmaceutical composition comprising said complex and method for application thereof
US 8652536 B2
申请人: DA LUZ MOREIRA PATRICIA
优先权: 2009
CN
US
3 件公开
Amycolatopsis sp. strain and methods of using the same for vanillin production
US 9115377 B2
申请人: ZHENG PU
优先权: 2011
US
3 件公开
UK-2 biosynthetic gene and method for improving UK-2 productivity using the same
US 9365879 B2
申请人: MEIJI SEIKA PHARMA CO LTD
优先权: 2012
US
3 件公开
Method For High-Purity Quaternary Ammonium Compounds
US 2008033209 A1
申请人: BASF AG
优先权: 2004
CN
US
2 件公开
Method for Producing High-Purity Quaternary Ammonium Compounds
US 2008009633 A1
申请人: BASF AG
优先权: 2004
CN
US
2 件公开
THE CO-CULTURE METHOD OF SPHINGOMONAS SP. BACTERIAL STRAIN AND ASPERGILLUS SP. FUNGUS STRAIN, NEW ANTI-CANCER AND ANTIBIOTIC GLIONITRINS DERIVED FROM THIS CO-CULTURE METHOD, AND PHARMACEUTICAL COMPOSITION CONTAINING GLIONITRINS OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS AN ACTIVE INGREDIENT
US 2010215620 A1
申请人: KOREA INST SCI & TECH
优先权: 2007
CN
US
2 件公开
PERONOSPORA RESISTANCE IN SPINACIA OLERACEA
EP 3518659 A1
申请人: RIJK ZWAAN ZAADTEELT EN ZAADHANDEL BV
优先权: 2016
EP
US
2 件公开
US 11202421 B2
申请人: RIJK ZWAAN ZAADTEELT EN ZAADHANDEL BV
优先权: 2016
US
US 10674688 B2
申请人: RIJK ZWAAN ZAADTEELT EN ZAADHANDEL BV
优先权: 2017
US
US 11820993 B2
申请人: RIJK ZWAAN ZAADTEELT EN ZAADHANDEL BV
优先权: 2020
US
US 11473102 B2
申请人: RIJK ZWAAN ZAADTEELT EN ZAADHANDEL BV
优先权: 2020
US
US 12520787 B2
申请人: RIJK ZWAAN ZAADTEELT EN ZAADHANDEL BV
优先权: 2021
US
第 1 / 10 页
上一页
下一页
药物
反馈